Quantum-dot-based homogeneous time-resolved fluoroimmunoassay of alpha-fetoprotein.

Quantum dots (QDs) with novel photoproperties are not widely used in clinic diagnosis, and homogeneous time-resolved fluorescence assays possess many advantages over current methods for alpha-fetoprotein (AFP) detection. A novel QD-based homogeneous time-resolved fluorescence assay was developed and used for detection of AFP, a primary marker for many cancers and diseases. QD-doped carboxyl-modified polystyrene microparticles (QPs) were prepared by doping oil-soluble QDs possessing a 605 nm emission peak. The antibody conjugates (QPs-E014) were prepared from QPs and an anti-AFP monoclonal antibody, and luminescent terbium chelates (LTCs) were prepared and conjugated to a second anti-AFP monoclonal antibody (LTCs-E010). In a double-antibodies sandwich structure, QPs-E014 and LTCs-E010 were used for detection of AFP, serving as energy acceptor and donor, respectively, with an AFP bridge. The results demonstrated that the luminescence lifetime of these QPs was sufficiently long for use in a time-resolved fluoroassay, with the efficiency of time-resolved Förster resonance transfer (TR-FRET) at 67.3% and the spatial distance of the donor to acceptor calculated to be 66.1Å. Signals from TR-FRET were found to be proportional to AFP concentrations. The resulting standard curve was logY=3.65786+0.43863·logX (R=0.996) with Y the QPs fluorescence intensity and X the AFP concentration; the calculated sensitivity was 0.4 ng mL(-1). By assaying test samples against the standard curve, the coefficient of variations was <5%, indicating that QDs were suitable for this homogenous time-resolved fluoroimmunoassay. This work extended the potential applications of QDs in future homogeneous analytical bioassays. In the coming research, hepatitis B surface antigen, another primary marker for hepatocellular carcinoma, will be studied for practical detection using a QD-based homogenous multiplex fluoroimmunoassay.

[1]  V. Uversky,et al.  Structure and function of α-fetoprotein: a biophysical overview , 2000 .

[2]  S. Sherlock,et al.  Diagnosis of Primary Cancer of the Liver , 1971, British medical journal.

[3]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[4]  S. Nie,et al.  Luminescent quantum dots for multiplexed biological detection and imaging. , 2002, Current opinion in biotechnology.

[5]  Steven C Kazmierczak,et al.  Nanodiagnostics: a new frontier for clinical laboratory medicine. , 2006, Clinical chemistry.

[6]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[7]  T. Tomasi.  Structure and function of alpha-fetoprotein. , 1977, Annual review of medicine.

[8]  E. Diamandis,et al.  Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. , 1995, Pharmacology & therapeutics.

[9]  T. Roux,et al.  Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a. , 2011, Analytical biochemistry.

[10]  T. Waldmann,et al.  The use of a radioimmunoassay for alpha‐fetoprotein in the diagnosis of malignancy , 1974, Cancer.

[11]  Hans-Gerd Löhmannsröben,et al.  Quantum dot biosensors for ultrasensitive multiplexed diagnostics. , 2010, Angewandte Chemie.

[12]  P. Selvin,et al.  Amine-reactive forms of a luminescent diethylenetriaminepentaacetic acid chelate of terbium and europium: attachment to DNA and energy transfer measurements. , 1997, Bioconjugate chemistry.

[13]  J E Hearst,et al.  Luminescence energy transfer using a terbium chelate: improvements on fluorescence energy transfer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  I. Hemmilä,et al.  Development of luminescent lanthanide chelate labels for diagnostic assays , 1997 .

[15]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[16]  Jianhao Wang,et al.  A flow cytometric assay technology based on quantum dots-encoded beads. , 2006, Analytica chimica acta.

[17]  A. Tuyns,et al.  Mean α-Fetoprotein Values of 1,333 Males over 15 Years by Age Groups , 1977 .

[18]  Xiaogang Peng,et al.  Experimental Determination of the Extinction Coefficient of CdTe, CdSe, and CdS Nanocrystals , 2003 .

[19]  R. Sutcliffe,et al.  Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. , 1972, Lancet.

[20]  Shimon Weiss,et al.  Synthesis and Properties of Biocompatible Water-Soluble Silica-Coated CdSe/ZnS Semiconductor Quantum Dots† , 2001 .

[21]  Hans-Gerd Löhmannsröben,et al.  Lanthanides to quantum dots resonance energy transfer in time-resolved fluoro-immunoassays and luminescence microscopy. , 2006, Journal of the American Chemical Society.

[22]  G. Mathis,et al.  Homogeneous immunoassays using rare earth cryptates and time resolved fluorescence: principles and specific advantages for tumor markers. , 1997, Anticancer research.

[23]  F. Izzo,et al.  Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. , 1998, Annals of surgery.

[24]  T. Lövgren,et al.  Europium as a label in time-resolved immunofluorometric assays. , 1984, Analytical biochemistry.

[25]  Niko Hildebrandt,et al.  Lanthanide Complexes and Quantum Dots: A Bright Wedding for Resonance Energy Transfer , 2008 .

[26]  A. Fletcher,et al.  Fluorescence quantum yields of some rhodamine dyes , 1982 .

[27]  Frank Morgner,et al.  A quantum-dot-based molecular ruler for multiplexed optical analysis. , 2010, Angewandte Chemie.

[28]  M. Duffy,et al.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. , 2010, Clinical chemistry.

[29]  G. Larcos,et al.  Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. , 1998, AJR. American journal of roentgenology.

[30]  B. Valeur,et al.  Molecular Fluorescence: Principles and Applications , 2001 .

[31]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.

[32]  L. Kricka.  Selected strategies for improving sensitivity and reliability of immunoassays. , 1994, Clinical chemistry.

[33]  M. Bawendi,et al.  Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites , 1993 .

[34]  Qingming Luo,et al.  Temperature-dependent photoluminescence of water-soluble quantum dots for a bioprobe , 2006 .

[35]  E. Rose,et al.  Alpha-fetoprotein levels in normal adults. , 1992, The American journal of the medical sciences.

[36]  A. O. Williams,et al.  Human Alpha Fetoprotein in Body Fluids , 1971, British Journal of Cancer.

[37]  S. Nie,et al.  Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules , 2001, Nature Biotechnology.

[38]  Xiaogang Peng,et al.  Kinetics of II-VI and III-V Colloidal Semiconductor Nanocrystal Growth: “Focusing” of Size Distributions , 1998 .

[39]  S. Schulman.  Fluorescence and phosphorescence spectroscopy : physicochemical principles and practice , 1977 .

[40]  M. S. Miranda,et al.  CdSe quantum dots capped PAMAM dendrimer nanocomposites for sensing nitroaromatic compounds. , 2011, Talanta.